Christopher John Morl, Chief Business Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 15,034 shares at $60.00 ($902K) on 2019-12-12, disclosed to the SEC on 2019-12-13.
Open-market sale of $902k DCPH by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2020-01-06 | $1.8M | — | Filing → |
| DCPH | SELL | 2019-12-11 | $827K | — | Filing → |
| DCPH | SELL | 2019-12-05 | $752K | — | Filing → |